Lv4
530 积分 2024-08-02 加入
HSP-CAR30 WITH A HIGH PROPORTION OF LESS-DIFFERENTIATED T CELLS PROMOTES DURABLE RESPONSES IN REFRACTORY CD30+ LYMPHOMA
4天前
求助中
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
5天前
已关闭
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia
5天前
已完结
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL
5天前
已完结
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
5天前
已完结
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
5天前
已完结
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
5天前
已完结
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia
5天前
已完结
Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody
5天前
已完结
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
5天前
已完结
皖公网安备34019202002308
